Charlotte's Web (cannabis)

Charlotte's Web (cannabis)

File:Drop of cannabis oil.jpg

A drop of cannabis oil, similar to the oil derived from Charlotte's Web.

Charlotte's Web is a cannabis strain and product line that is renowned for its high cannabidiol (CBD) content and low tetrahydrocannabinol (THC) levels. It was developed by the Stanley Brothers in Colorado, United States, and gained international attention for its use in treating epilepsy, particularly in children.

History

Charlotte's Web was named after Charlotte Figi, a young girl with Dravet syndrome, a severe form of epilepsy. Her condition improved significantly after using the oil derived from this strain, which led to widespread media coverage and increased interest in the medical use of cannabis.

Composition

Charlotte's Web is characterized by its high CBD content, which can be as high as 20%, and its low THC content, typically less than 0.3%. This makes it non-psychoactive, meaning it does not produce the "high" associated with other cannabis strains.

Uses

The primary use of Charlotte's Web is in the treatment of seizures and epilepsy. It has also been used to alleviate symptoms of other conditions such as anxiety, pain, and inflammation. The oil is typically administered orally.

Legal Status

Due to its low THC content, Charlotte's Web is legal in many jurisdictions where other forms of cannabis are not. However, the legal status can vary significantly between different countries and states.

Cultivation

Charlotte's Web is cultivated under strict conditions to ensure its high CBD and low THC content. The Stanley Brothers continue to oversee its production to maintain quality and consistency.

Related pages

• Cannabis (drug)
• Cannabidiol
• Tetrahydrocannabinol
• Epilepsy
• Medical cannabis